Minnesota Moves Forward With Psilocybin Therapy Plan, Eyes Broader Psychedelic Reforms
The Minnesota Psychedelic Medicine Task Force (PMTF) is making strides toward finalizing a set of recommendations on how the state might regulate psychedelic substances, including psilocybin, MDMA and LSD. According to Marijuana Moment, the group has already approved the creation of a state-regulated clinical psilocybin therapy program and allocated funding for research into the therapeutic potential of these substances. However, broader reforms, such as eliminating penalties for personal possession, remain unresolved.
The workgroup, created by legislation signed into law by Governor Tim Walz in 2023, is tasked with advising lawmakers on the legal, medical and policy frameworks for psychedelic medicine. PMTF is expected to submit a comprehensive report by January 1, 2025, but ongoing debates within the task force reflect broader societal tensions surrounding psychedelic decriminalization.